The COVID-19 pandemic is changing everything about our lives and how we interact with the world around us. We have always been grateful for the healthcare professionals that keep us all healthy and safe, but in this impossible time we are even more thankful for...
Last week we had the pleasure of sitting down with Dan Sfera and Chris Sauber from The Clinical Trials Guru to discuss artificial intelligence in clinical trials. Watch the full video with Deep 6 AI CEO Wout Brusselaers below, but here are a few discussion topics...
It’s hard to wrap one's mind around the coronavirus (COVID-19) outbreak and what it means for society. There’s a lot we don’t know and this is the first time we’ve had to deal with a global pandemic of this magnitude. In addition, the situation is...
The team at NVIDIA published an article discussing how Deep 6 is leveraging NVIDIA hardware to train and improve the NLP and AI that power our patient-matching platform. Here’s a snippet from the article: “Many people in medicine have ideas of how to improve healthcare,” said Wout...
Last week Deep 6 AI's Vice President of Marketing, Emily Hossellman, published an article reflecting on her impressions about the industry after 90 days with the Deep 6 team. She detailed the opportunity and the challenges in front of the industry and Deep 6 as...
Our CEO, Wout Brusselaers, was featured on OC Talks last week, a podcast from Oncology Central. In this discussion, he outlines the challenges most researchers face when finding patients for clinical trials. He specifically addresses some of the unique challenges that come with recruiting patients for...
The Deep 6 AI team enjoyed a busy few days at MAGI West in Las Vegas last week. Over 700 industry professionals attended more than 100 sessions and workshops to learn from each other about how they can improve their clinical research operations. We joined...
Deep 6 AI's success with Cedars-Sinai was recently discussed in an article from Nature on "An AI boost for clinical trials". The article outlines the outdated and challenging methods researchers use to find and recruit patients for crucial clinical trials. Then the article details how software...
We’re thrilled to share that Forbes chose to include Deep 6 AI on its AI 50 list of America’s Most Promising Artificial Intelligence Companies. The list focused on “U.S.-based companies that are wielding some subset of artificial intelligence in a meaningful way and demonstrating real...
Our CEO, Wout Brusselaers, was featured on Under the DataScope, a podcast created by the Kraft Precision Medicine Accelerator at Harvard Business School. In this discussion, he covers the story of how Deep 6 made the move from working for a large US Intelligence agency, to...